Physician profile
Abdul Ali
NPI 1598734121
$12,203.64
in general payments reported to CMS, 2019-2025
55 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,198 · 2020: $1,803 · 2021: $1,908 · 2022: $1,909 · 2023: $2,113 · 2024: $1,031 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,385.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,141.89 | 2019-2023 | Coroflow, Diamondback Coronary, Assurity |
| Janssen Pharmaceuticals, INC | $860.20 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $713.24 | 2019-2025 | Watchman Flx, Bodyguardian, Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $610.16 | 2020-2025 | Farxiga, Lokelma |
| Amgen INC. | $608.02 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $479.35 | 2021-2025 | Verquvo, Winrevair, Belsomra |
| Novartis Pharmaceuticals Corporation | $432.07 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $377.07 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $343.50 | 2019-2025 | Opsumit, Uptravi |
| Shockwave Medical, INC | $291.95 | 2019-2025 | |
| Akcea Therapeutics, INC. | $272.68 | 2019-2021 | |
| Pfizer INC. | $272.31 | 2019-2023 | |
| Ablative Solutions, INC. | $267.39 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $265.77 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.18 | 2019-2025 | Lifevest |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $237.75 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $234.94 | 2021-2024 | Ozempic, Rybelsus |
| Lundbeck LLC | $222.95 | 2019-2021 | |
| Cleerly, INC. | $185.70 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Impulse Dynamics (USA) INC. | $177.38 | 2022 | |
| Esperion Therapeutics, INC. | $174.98 | 2020-2022 | |
| Abiomed | $154.30 | 2019 | |
| Astellas Pharma US INC | $145.90 | 2019-2024 | Veozah |
| Nevro Corp. | $144.34 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $121.40 | 2022-2023 | Arcalyst |
| Amarin Pharma, INC. | $109.49 | 2019-2022 | |
| Medtronic, INC. | $81.91 | 2023 | Linq II |
| Alnylam Pharmaceuticals INC. | $81.86 | 2023 | Amvuttra |
| Azurity Pharmaceuticals, INC. | $78.64 | 2024 | Edarbi |
| Lexicon Pharmaceuticals, INC. | $70.65 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $63.84 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $61.95 | 2020-2022 | |
| Medtronic Vascular, INC. | $49.99 | 2019 | |
| Edwards Lifesciences Corporation | $47.74 | 2025 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $47.20 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $46.29 | 2024-2025 | Assure Wcd |
| Preventice Services, LLC | $40.17 | 2020-2021 | |
| Bardy Diagnostics, INC. | $40.00 | 2019-2020 | |
| Philips North America LLC | $37.50 | 2019 | |
| Gilead Sciences, INC. | $35.93 | 2019 | |
| Scpharmaceuticals INC. | $32.83 | 2025 | |
| Bolton Medical INC | $30.42 | 2023 | Treo Abdominal Stent-Graft System |
| Endologix LLC | $26.00 | 2019 | |
| Aspira Women'S Health INC | $25.60 | 2024 | Ova1 |
| Surmodics, INC. | $25.22 | 2022 | |
| Irhythm Technologies, INC. | $25.19 | 2023 | Zio Xt Patch |
| Biotronik INC. | $22.37 | 2020 | |
| Tactile Systems Technology INC | $21.60 | 2025 | Flexitouch Plus, Nimbl |
| Mayne Pharma Commercial LLC | $20.54 | 2022 | |
| Medicomp INC | $19.19 | 2021 | |
| Agepha Pharma Fz LLC | $18.23 | 2024 | Lodoco |
| Lilly USA, LLC | $15.74 | 2022 | |
| Myocardial Solutions, INC. | $15.06 | 2021 | |
| Cashflow Solutions, LLC | $14.14 | 2022 | |
| Genzyme Corporation | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.